Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 03 - 01 tags : Earnings save search
Cara Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 23:00) - biospace.com/
CARA | $0.7097 -2.83% -2.92% 180K
|
Health Technology
|
| O: -0.39%
H: 2.13%
C: -2.61%
financial results therapeutics report results
Syndax Pharmaceuticals Reports Fourth Quarter 2021 Financial Results and Provides Clinical and Business Update
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
SNDX | $20.95 -0.05% -0.05% 870K
|
Health Technology
|
| O: -0.64%
H: 4.26%
C: 3.68%
als financial results report results
REGENXBIO Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Operational Highlights
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 2.9%
H: 0.0%
C: -1.59%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: 0.0%
RARE F | $45.06 3.14% 3.04% 840K
|
Health Technology
|
| O: -0.42%
H: 2.66%
C: 0.49%
RCKT M | $23.705 -0.69% -0.7% 450K
|
Health Technology
|
| O: 0.56%
H: 0.22%
C: -6.92%
RGNX | $15.885 1.57% 1.54% 360K
|
Health Technology
|
| O: 0.34%
H: 2.79%
C: 0.57%
financial results report results
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Pipeline and Business Progress
Published: 2022-03-01 (Crawled : 22:00) - biospace.com/
PHAT | $9.05 0.44% 0.44% 580K
|
Health Technology
|
| O: -0.17%
H: 1.27%
C: 0.17%
als financial results report results
Cerevel Therapeutics Provides Update on Pipeline Progress along with Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
CERE | $41.99 -0.26% -0.26% 1.4M
|
Finance
|
| O: -1.25%
H: 13.96%
C: 8.53%
financial results therapeutics results
Seres Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: 0.0%
financial results therapeutics report results
Axsome Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
AXSM | $73.055 2.75% 2.68% 700K
|
Health Technology
|
| O: 1.8%
H: 0.0%
C: 0.0%
financial results therapeutics report results
Novanta Announces Financial Results for the Fourth Quarter and Full Year 2021
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
NOVT | $159.33 4.06% 3.9% 170K
|
Electronic Technology
|
| O: -1.19%
H: 1.39%
C: -3.5%
financial results ces results
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 16:00) - biospace.com/
BCYC | $22.68 0.49% 0.49% 160K
|
Health Technology
|
| O: -2.74%
H: 6.28%
C: 2.38%
financial results therapeutics report results
Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Business Update on March 10, 2022
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
LCTX | $1.14 0.0% 330K
|
Health Technology
|
| O: -0.71%
H: 2.26%
C: -2.14%
financial results therapeutics cel report results
Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
ITCI 4 d | $73.96 -0.78% -0.78% 830K
|
Health Technology
|
| O: -0.87%
H: 7.05%
C: 2.73%
financial results cel report results therapy
Horizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
HZNP | $116.3 0.03% 29M
|
Health Technology
|
| O: 3.13%
H: 0.0%
C: 0.0%
financial results ces therapeutics report results
Precigen Reports Fourth Quarter and Full Year 2021 Financial Results
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
PGEN | $1.4 1.45% 1.43% 510K
|
Health Technology
|
| O: -4.89%
H: 4.21%
C: 0.93%
financial results report results
Minerva Neurosciences Reports Fourth Quarter 2021 Financial Results and Business Updates
Published: 2022-03-01 (Crawled : 15:00) - biospace.com/
NERV | $2.55 0.0% 4.6K
|
Health Technology
|
| O: -0.79%
H: 5.62%
C: -1.41%
financial results report results
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2021 Financial Results Conference call to be held today, Tuesday, March 1, 2022, at 8:30 AM ET
Published: 2022-03-01 (Crawled : 14:00) - biospace.com/
TGTX | $14.25 1.06% 1.05% 3.2M
|
Health Technology
|
| O: 0.91%
H: 5.9%
C: 2.9%
day financial results conference therapeutics report results oda
Epizyme Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
EPZM | $1.47 -1.34% 0.0%
|
Health Technology
|
| O: -15.54%
H: 29.6%
C: 27.2%
financial results report results
Forma Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
FMTX | $20.01 -0.15%
|
Health Technology
|
| O: -2.24%
H: 7.47%
C: -1.59%
financial results therapeutics report results
Quanterix Corporation Releases Operating Results for Fourth Quarter and Full Year 2021
Published: 2022-03-01 (Crawled : 13:00) - biospace.com/
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 1.26%
H: 0.0%
C: 0.0%
ABT | News | $107.59 0.49% -0.09% 3.8M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
QTRX | $16.085 -1.32% -1.34% 340K
|
Health Technology
|
| O: 3.95%
H: 6.39%
C: -6.56%
corporation results
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
Published: 2022-03-01 (Crawled : 12:00) - biospace.com/
ZYNE | $1.3 3.08% 860K
|
Health Technology
|
| O: 0.91%
H: 3.38%
C: -2.7%
als financial results report results
Amarin Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Published: 2022-03-01 (Crawled : 12:00) - biospace.com/
AMRN | News | $0.8827 1.96% 1.93% 760K
|
Health Technology
|
| O: 3.72%
H: 1.19%
C: -4.78%
financial results report results
Gainers vs Losers
| 79% | 21% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 870K
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.